Drug Approval Package
-
Risperdal Consta Long-Acting
Injection
Company: Johnson & Johnson Pharmaceutical Research
Application No.: 021346
Approval Date: 10/29/2003
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Medical Review(s) (PDF)
-
Chemistry Review(s) (PDF)
-
Pharmacology Review(s) (PDF)
-
Statistical Review(s) (PDF)
-
Microbiology Review(s) (PDF)
-
Correspondence (PDF)
Date created: June 152005
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-